The goal of this observational study is to learn about the clinical spectrum of sellar masses, aiming to understand the correlation between the imaging features and the future surgical approach and histopathology results.

The main question it aims to answer is:

Does being both LMIC and conflict country change the global data!? Participants were included during a period of 3 years in a governmental hospital TMGH.

Inclusion Criteria:

• Radiologically confirmed sellar, suprasellar, or parasellar mass.
• Surgical candidacy
• Histopathological confirmation
• Age ≥ 11 year

Exclusion Criteria:

• Incomplete diagnostics
• Recurrent disease
• Primary metastatic disease.

included all Patients presenting with sellar region masses from December 2022 to December 2025, at Neurosurgical department at TMGH

Individual participant data will not be shared publicly to protect patient confidentiality and privacy. The informed consent obtained from the participants covers the publication of aggregated study findings within the manuscript and tables only, and does not include explicit permission for the public disclosure of raw, de-identified individual clinical or radiological datasets."